Published by Josh White on 3rd March 2026
(Sharecast News) - Shield Therapeutics said the Chinese National Medical Products Administration has accepted a marketing authorisation application for Accrufer, or ferric maltol, for the treatment of iron deficiency in adults.
URL: http://www.digitallook.com/dl/news/story/35757488/...